Epigenomics Market Size, Forecast 2030

According to the new research report published by Precedence Research, titled “Epigenomics Market (By Product: Reagents, Kits, Instruments, Enzymes, Services; By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large non – coding RNA, MicroRNA modification, Chromatin structures; By Application: Oncology, Non oncology) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the global epigenomics market  poised to record a yearly growth rate of 13.7% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.

This report focuses on epigenomics market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall epigenomics market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.

 The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2342

The study also provides important advancements in organic and inorganic growth strategies in the worldwide epigenomics market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of epigenomics market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.

Epigenomics Market Report Scope 

Also read: Lithium Titanate Batteries Market Size to Worth US$ 178.19 Billion by 2030

Market Key Players

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the epigenomics market.

Some of the prominent players in the epigenomics market include are

• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Illumina, Inc. (US)
•  PacBio (US)
• Abcam plc (UK)
• Active Motif
• Bio-Rad Laboratories (US)
• Promega Corporation (US)
• PerkinElmer (US)
• Qiagen (Germany)
• New England Biolabs (US)
• Zymo Research Corporation (US)
• Diagenode (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Illumina, Inc. (US)
•  PacBio (US)
• Abcam plc (UK)
• Active Motif
• Bio-Rad Laboratories (US)
• Promega Corporation (US)
• PerkinElmer (US)
• Qiagen (Germany)
• New England Biolabs (US)
• Zymo Research Corporation (US)
• Diagenode (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)

Epigenomics Market Segmentations 

By Product 

• Reagents
• Kits
  • Chip sequencing kit
  • Whole Genomic Amplification kit
  • Bisulfite Conversion kit
  • RNA Sequencing Kit
  • Others
• Instruments
• Enzymes
• Services

By Technology 

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large non-coding RNA
• MicroRNA Modification
• Chromatin Structures

By Application 

• Oncology
• Non oncology

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives 

• To define, segment, and project the global market size for epigenomics market
• To understand the structure of the market by identifying its various sub-segments
• To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
• To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
• To profile key players and comprehensively analyze their core competencies
• To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
• To analyze the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements 

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Epigenomics Market 

5.1. COVID-19 Landscape: Epigenomics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Epigenomics Market, By Product

8.1. Epigenomics Market, by Product, 2022-2030

8.1.1 Reagents

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Kits

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Kits

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Whole Genomic Amplification kit

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Bisulfite Conversion kit

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. RNA Sequencing Kit

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Instruments

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Enzymes

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Services

8.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Epigenomics Market, By Technology

9.1. Epigenomics Market, by Technology, 2022-2030

9.1.1. DNA Methylation

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Histone Methylation

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Histone Acetylation

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Large non-coding RNA

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. MicroRNA Modification

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Chromatin Structures

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Epigenomics Market, By Application 

10.1. Epigenomics Market, by Application, 2022-2030

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Non oncology

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Epigenomics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific (US)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Merck KGaA (Germany)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Illumina, Inc. (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. PacBio (US)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abcam plc (UK)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Active Motif

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories (US)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Promega Corporation (US)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. PerkinElmer (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Qiagen (Germany)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global epigenomics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for epigenomics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

 

---